Search results
Ocuphire Pharma, Inc. (OCUP) Just Flashed Golden Cross Signal: Do You Buy?
Zacks via Yahoo Finance· 1 year agoFrom a technical perspective, Ocuphire Pharma, Inc. (OCUP) is looking like an interesting pick, as...
Ocuphire (OCUP) to Report Q4 Earnings: What's in the Cards?
Zacks via Yahoo Finance· 2 months agoOcuphire (OCUP) is expected to provide updates on the clinical development of its lead retinal...
Bears are Losing Control Over Ocuphire Pharma, Inc. (OCUP), Here's Why It's a 'Buy' Now
Zacks via Yahoo Finance· 5 months agoOcuphire Pharma, Inc. (OCUP) witnesses a hammer chart pattern, indicating support found by the stock...
Does Ocuphire Pharma, Inc. (OCUP) Have the Potential to Rally 323.89% as Wall Street Analysts...
Zacks via Yahoo Finance· 1 year agoThe mean of analysts' price targets for Ocuphire Pharma, Inc. (OCUP) points to a 323.9% upside in...
Ocuphire Pharma, Inc. (OCUP) Is a Great Choice for 'Trend' Investors, Here's Why
Zacks via Yahoo Finance· 1 year agoOcuphire Pharma, Inc. (OCUP) made it through our "Recent Price Strength" screen and could be a great...
Ocuphire Pharma, Inc. (OCUP) is a Great Momentum Stock: Should You Buy?
Zacks via Yahoo Finance· 1 year agoMomentum investing is all about the idea of following a stock's recent trend, which can be in either...
Earnings Update: Ocuphire Pharma, Inc. (NASDAQ:OCUP) Just Reported And Analysts Are Trimming Their...
Simply Wall St. via Yahoo Finance· 2 months agoOcuphire Pharma, Inc. (NASDAQ:OCUP) just released its latest yearly report and things are not...
Is Ocuphire Pharma, Inc.'s (NASDAQ:OCUP) Recent Stock Performance Influenced By Its Fundamentals In...
Simply Wall St. via Yahoo Finance· 12 months agoOcuphire Pharma's (NASDAQ:OCUP) stock is up by a considerable 60% over the past three months. As...
The Market Lifts Ocuphire Pharma, Inc. (NASDAQ:OCUP) Shares 42% But It Can Do More
Simply Wall St. via Yahoo Finance· 1 year agoOcuphire Pharma, Inc. (NASDAQ:OCUP) shareholders have had their patience rewarded with a 42% share...
Ocuphire Pharma, Inc. (NASDAQ:OCUP) About To Shift From Loss To Profit
Simply Wall St. via Yahoo Finance· 1 year agoOcuphire Pharma, Inc. (NASDAQ:OCUP) is possibly approaching a major achievement in its business, so...